导致肝脓肿的肠杆菌科细菌的耐药性分析

周宜庆; 曾敏; 周洁; 阮永春; 张海旺; 苏美霞; 何薇; 李明晖

doi:10.3969/j.issn.1001-5256.2018.08.031

导致肝脓肿的肠杆菌科细菌的耐药性分析

DOI: 10.3969/j.issn.1001-5256.2018.08.031

绍兴市人民医院感染科

基金项目:

浙江省医药卫生科技计划项目(2018KY830,2017KY151)；绍兴市公益性技术应用研究计划项目(2017B70030)；

详细信息

中图分类号: R446.5;R575.4
计量
- 文章访问数: 2062
- HTML全文浏览量: 27
- PDF下载量: 385
- 被引次数: 0
出版历程
- 收稿日期: 2018-03-01
- 出版日期: 2018-08-20

Drug resistance of Enterobacteriaceae bacteria causing liver abscess

Department of Infectious Diseases, Shaoxing People's Hospital

Research funding:

摘要

摘要:
目的分析导致肝脓肿的肠杆菌科细菌耐药情况,指导抗生素应用。方法以2014年1月-2017年12月在绍兴市人民医院住院并分离到肠杆菌科细菌的肝脓肿患者为研究对象。分析其临床资料、一般实验室检查结果、病原体耐药数据、治疗方法及结局。结果 53例患者中,基础疾病主要包括胆囊、胆道疾病或手术史28例（52.8%）,高血压病20例（37.7%）,糖尿病18例（34.0%）;临床表现:发热51例（96.2%）,肝区疼痛或胃肠道症状33例（62.3%）,休克6例（11.3%）。31例（58.5%）白细胞计数>10×109/L,37例（69.8%）中性粒细胞计数升高,50例（94.3%）CRP升高,17/19例（89.5%）PCT升高,32例（60.4%）ALT升高,22例（41.5%）AST升高。血培养阳性11例,其中肺炎克雷伯杆菌7例（63.6%）,大肠杆菌4例（36.4%）。脓液或胆汁培养肠杆菌科细菌株53例,包括肺炎克雷伯杆菌35例（66.0%）,大肠杆菌12例（22.6%）,摩氏摩根菌亚种2例（3.8%）,彭氏变形杆菌、雷氏普罗威登斯菌、弗氏柠檬酸杆菌、奇异变形杆菌各1例（1.9%）。...
- 肝脓肿 /
- 克雷伯菌,肺炎 /
- 大肠杆菌 /
- 抗药性 /
- 治疗学
Abstract:
Objective To investigate the drug resistance of Enterobacteriaceae bacteria which cause liver abscess, and to guide the application of antibiotics. Methods The patients with liver abscess who were hospitalized in our hospital from January 2014 to December 2017 and were found to have Enterobacteriaceae bacteria by isolation were enrolled as research subjects. Their clinical data, laboratory examination results, drug resistance data, treatment method, and outcomes were analyzed. Results Among the 53 patients, 28 ( 52. 8%) had gallbladder and biliary diseases or a surgical history, 20 ( 37. 7%) had hypertension, and 18 ( 34. 0%) had diabetes; as for clinical manifestations, 51 ( 96. 2%) had pyrexia, 33 ( 62. 3%) had liver pain or gastrointestinal symptoms, and 6 ( 11. 3%) had septic shock. Among these patients, 31 ( 58. 5%) had a leukocyte count of > 10 × 109/L, 37 ( 69. 8%) had an increase in neutrophil count, 50 ( 94. 3%) had an increase in C-reactive protein, 32 ( 60. 4%) had an increase in alanine aminotransferase, and 22 ( 41. 5%) had an increase in aspartate aminotransferase; among the 19 patients who underwent procalcitonin ( PCT) measurement, 17 ( 89. 5%) were found to have an increase in PCT. A total of 11 patients had a positive blood culture, among whom 7 ( 63. 6%) had Klebsiella pneumoniae and 4 ( 36. 4%) had Escherichia coli. Pus or bile culture identified Enterobacteriaceae bacteria strains in the 53 patients, among whom 35 ( 66. 0%) had Klebsiella pneumoniae, 12 ( 22. 6%) had Escherichia coli, 2 ( 3. 8%) had Morganella morganii subspecies, and 1 ( 1. 9%) each had Proteus penneri, Providencia rustigianii, Citrobacter freundii, and Proteus mirabilis. Among the 35 patients with Klebsiella pneumoniae, 2 had extended-spectrum beta-lactamase ( ESBL) -producing Klebsiella pneumoniae, and among the 12 patients with Escherichia coli, 9 had ESBL-producing Escherichia coli; Klebsiella pneumoniae strains were sensitive to common antibiotics, while Escherichia coli strains had high drug resistance rates to second-and third-generation cephalosporins, quinolones, and aminoglycosides. All isolates were highly sensitive to carbapenems. Conclusion Enterobacteriaceae bacteria causing liver abscess has a low ESBL-positive rate. Third-generation cephalosporins and antibiotics containing β-lactamase inhibitors are major regimens for initial empiric therapy.
- liver abscess /
- klebsiella pneumoniae /
- escherichia coli /
- drug resistance /
- therapeutics

HTML全文

参考文献(15)

[1]CHEN F, ZHANG YT, QIAO HJ, et al.Clinical fealthers of klebsiella pneumoniae liver abscess[J].J Clin Hepatol, 2016, 32 (4) :746-768. (in Chinese) 陈帆, 张艳亭, 乔慧捷, 等.肺炎克雷伯菌肝脓肿的临床特征分析[J].临床肝胆病杂志, 2016, 32 (4) :746-768.

[2]TIAN L, CHEN ZJ, SUN ZY, et al.Antibiotic resistance profile of Enterobacter in hospitals across China:Data from CHINET antimicrobial resistance surveillance program from 2005 through 2014[J].Chin J Infect Chemother, 2016, 16 (3) :275-283. (in Chinese) 田磊, 陈中举, 孙自镛, 等.2005-2014年CHINET肠杆菌属细菌耐药性监测[J].中国感染与化疗杂志, 2016, 16 (3) :275-283.

[3]XU A, ZHUO C, SU DH, et al.Changing susceptibility of Klebsiella strains in hospitals across China:Data from the CHINET antimicrobial resistance surveillance program, 2005-2014[J].Chin J Infect Chemother, 2016, 16 (3) :267-274. (in Chinese) 徐安, 卓超, 苏丹虹, 等.2005-2014年CHINET克雷伯菌属细菌耐药性监测[J].中国感染与化疗杂志, 2016, 16 (3) :267-274.

[4]LI XJ, WANG B, XIONG H.Clinical characteristics and bacterial distribution in patients with diabetes companied with pyogenic hepatic abscess[J].Chin J Clin Pharmacol, 2015, 31 (3) :232-234. (in Chinese) 李晓晶, 汪波, 熊辉.糖尿病合并肝脓肿的临床特点及其感染细菌分布[J].中国临床药理学杂志, 2015, 31 (3) :232-234.

[5]ZHANG TT, YUAN Z.Analysis on distribution of bacterial etiology and drug resistance of pyogenic liver abscess[J].Med J West China, 2017, 29 (5) :679-684. (in Chinese) 张婷婷, 袁喆.细菌性肝脓肿病原学分布及耐药性分析[J].西部医学, 2017, 29 (5) :679-684.

[6]PERIS J, BELLOT P, ROIG P, et al.Clinical and epidemiological characteristics of pyogenic liver abscess in people 65 years or older versus people under 65:A retrospective study[J].BMC Geriatr, 2017, 17 (1) :161.

[7]CHO H, LEE ES, LEE YS, et al.Predictors of septic shock in initially stable patients with pyogenic liver abscess[J].Scand J Gastroenterol, 2017, 52 (5) :589-594.

[8] ZHOU YQ, ZHOU J, ZENG M, et al.The clinical features of 93bacterial liver abscess cases[J].J Chin Physician, 2017, 19 (10) :1524-1527. (in Chinese) 周宜庆, 周洁, 曾敏, 等.93例细菌性肝脓肿患者临床特征分析[J].中国医师杂志, 2017, 19 (10) :1524-1527.

[9]FAZILI T, SHAMGOE C, ENDY T, et al.Klebsiella pneumoniae liver abscess:An emerging disease[J].Am J Med Sci, 2016, 351 (3) :297-304.

[10]FUNG CP, CHANG FY, LEE SC, et al.A global emerging disease of Klebsiella pneumoniae liver abscess:Is serotype K1 an important factor for complicated endophthalmitis?[J].Gut, 2002, 50 (3) :420-424.

[11]LEE IR, MOLTON JS, WYRES KL, et al.Differential host susceptibility and bacterial virulence factors driving Klebsiella liver abscess in an ethnically diverse population[J].Sci Rep, 2016, 6:29316.

[12] National Health and Family Planning Commission Medical and Health Authority.Notice of the General Office of the Health and Family Planning Commission of the People's Republic of China on Further Strengthening the Management of Antibiotics for Clinical Applications to Control Bacterial Resistance[R/OL].http://www.nhfpc.gov.cn/yzygj/s7659/201703/d2f580480cef4ab1b976542b550f36cf.shtml, 2017. (in Chinese) 国家卫计委医政医管局.国家卫生计生委办公厅关于进一步加强抗菌药物临床应用管理遏制细菌耐药的通知[R/OL].http://www.nhfpc.gov.cn/yzygj/s7659/201703/d2f580480cef4ab1b976542b550f36cf.shtml, 2017.

[13]MAVILIA MG, MOLINA M, WU GY.The Evolving nature of hepatic abscess:A review[J].J Clin Transl Hepatol, 2016, 4 (2) :158-168.

[14]HAIDER SJ, TARULLI M, MCNULTY NJ, et al.Liver abscesses:Factors that influence outcome of percutaneous drainage[J].AJR Am J Roentgenol, 2017, 209 (1) :205-213.

[15]RISMILLER K, HAAGA J, SIEGEL C, et al.Pyogenic liver abscesses:A contemporary analysis of management strategies at a tertiary institution[J].HPB (Oxford) , 2017, 19 (10) :889-893.

施引文献

资源附件(0)

访问统计